ALPHA 1-ANTITRYPSIN - ANVISA Registration 10033120434

Access comprehensive regulatory information for ALPHA 1-ANTITRYPSIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10033120434 and manufactured by BECKMAN COULTER INC. The registration is held by BECKMAN COULTER DO BRASIL COMÉRCIO E IMPORTAÇÃO DE PRODUTOS DE LABORATÓRIO LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including DIAGAM S.A., IMMUNDIAGNOSTIK AG, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10033120434
Registration Details
ANVISA Registration Number: 10033120434
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

IMMAGE Alpha-1-Antitrypsin Reagent
Risk Class II

Registration Details

10033120434

25351039615200417

42160812000144

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Jul 15, 2004

VIGENTE

09/18/2025 19:00:01